Percutaneous coronary intervention in patients with essential thrombocythemia: case reports and literature review

References

• Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management. Am J Hematol 2015;90(2):162–173. doi:10.1002/ajh.23895.
   PubMed Web of Science ®Google Scholar
• Kumagai N, Mitsutake R, Miura S, Kawamura A, Takamiya Y, Nishikawa H, Uehara Y, Saku K. Acute coronary syndrome associated with essential thrombocythemia. J Cardiol 2009;54(3):485–489. doi:10.1016/j.jjcc.2009.03.001.
   PubMed Web of Science ®Google Scholar
• Bildirici U, Celikyurt U, Ural E. Essential thrombocythemia: a case of acute ST-segment elevation myocardial infarction in a young female. Clin Cardiol 2009;32(2):104–105. doi:10.1002/clc.20426.
   PubMed Web of Science ®Google Scholar
• Rossi C, Randi ML, Zerbinati P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med 1998;244(1):49–53. doi:10.1046/j.1365-2796.1998.00314.x.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Fujinaga H, Ikeda Y, Higashi T, Murakami M, Kawahara K, Hayashi I, Niki T, Shigekiyo T, Wakatsuki T. Acute myocardial infarction in a patient with essential thrombocythemia who underwent successful stenting–a case report. Angiology 2005;56(6):771–774. doi:10.1177/000331970505600616.
   PubMed Web of Science ®Google Scholar
• Kaifie A, Kirschner M, Wolf D, Maintz C, Hanel M, Gattermann N, Gokkurt E, Platzbecker U, Hollburg W, Gothert JR, et al. Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry. J Hematol Oncol 2016;9:18. doi:10.1186/s13045-016-0242-9.
   PubMed Web of Science ®Google Scholar
• Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Vannucchi AM, Antonioli E, et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood 2011;117(22):5857–5859. doi10.1182/blood-2011-02-339002.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Akaike M, Kato M, Takamori N, Abe M, Nishiuchi T, Azuma H, Matsumoto T. Aggressive antiplatelet therapy before coronary stent implantation in acute coronary syndrome with essential thrombocythemia–a case report. Angiology 2003;54(4):485–490. doi10.1177/000331970305400414.
   PubMed Web of Science ®Google Scholar
• Singla A, Jagasia D, Garg M, Lowry PA, Stapleton D. Acute ST-segment elevation myocardial infarction: a rare initial presentation of previously undiagnosed essential thrombocythemia. Platelets 2012;23(6):463–466. doi:10.3109/09537104.2011.640966.
   PubMed Web of Science ®Google Scholar
• Katranas SA, Kelekis AL, Antoniadis AP, Ziakas AG, Giannoglou GD. Differences in stress forces and geometry between left and right coronary artery: a pathophysiological aspect of atherosclerosis heterogeneity. Hellenic J Cardiol 2015;56(3):217–223.
   PubMed Web of Science ®Google Scholar
• Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost 2006;32(6):589–604. doi:10.1055/s-2006-949664.
   PubMed Web of Science ®Google Scholar
• Gao W, Shen W, Luo X, Shi H, Jiang X, Pan J. ST-segment elevation myocardial infarction in patient with essential thrombocythemia without associated risk. Int J Cardiol 2015;180:223–225. doi:10.1016/j.ijcard.2014.11.147.
   PubMed Web of Science ®Google Scholar
• Hanger KH Jr., Kilgore J, James E. Essential thrombocythemia and coronary artery disease. Chest 1984;86(6):933–935. doi:10.1378/chest.86.6.933.
   PubMed Web of Science ®Google Scholar
• Turgut T, Harjai KJ, Edupuganti R, Cole J, Jenkins JS, Ramee SR, Collins TJ. Acute coronary occlusion and in-stent thrombosis in a patient with essential thrombocythemia. Cathet Cardiovasc Diagn 1998;45(4):428–433. doi:10.1002/(ISSN)1097-0304.
   PubMedGoogle Scholar
• Terada H, Satoh H, Uehara A. Multivessel coronary thrombosis, acute myocardial infarction, and no reflow in a patient with essential thrombocythaemia. Heart 2000;83(6):E10. doi:10.1136/heart.83.6.e10.
   PubMedGoogle Scholar
• Mizuta E, Takeda S, Sasaki N, Miake J, Hamada T, Shimoyama M, Tajima F, Igawa O, Shigemasa C, Hisatome I. Acute myocardial infarction in a patient with essential thrombocythemia: successful treatment with percutaneous transluminal coronary recanalization. Circ J 2005;69(8):1000–1002. doi:10.1253/circj.69.1000.
   PubMed Web of Science ®Google Scholar
• Chang H, Shim CY, Cheong JW, Pyo JY, Ko YG, Choi D, Jang Y. Coronary artery intervention after cytostatics treatment in unstable angina patient with essential thrombocythemia. A case report and literature review. Korean J Intern Med 2006;21(2):146–149. doi:10.3904/kjim.2006.21.2.146.
   PubMedGoogle Scholar
• Ozben B, Ekmekci A, Bugra Z, Umman S, Meric M. Multiple coronary thrombosis and stent implantation to the subtotally occluded right renal artery in a patient with essential thrombocytosis: a case report with review. J Thromb Thrombolysis 2006;22(1):79–84. doi:10.1007/s11239-006-7790-8.
   PubMed Web of Science ®Google Scholar
• Kelly SV, Burke RF, Lee KS, Torloni AS, Lee RW, Northfelt D, Fonseca R. Acute myocardial infarction: an unusual presentation of essential thrombocytosis in a 17-year-old man. Clin Adv Hematology Oncol 2008;6(2):133–136.
   PubMedGoogle Scholar
• Campo G, Valgimigli M, Carletti R, Fileti L, Ferrari R. Long-term outcome after percutaneous coronary intervention in patients with essential thrombocythemia. J Thromb Haemost 2009;7(7):1235–1238. doi:10.1111/j.1538-7836.2009.03469.x.
   PubMed Web of Science ®Google Scholar
• Lim YH, Lee YY, Kim JH, Shin J, Lee JU, Kim KS, Kim SK, Kim JH, Lim HK. Development of acute myocardial infarction in a young female patient with essential thrombocythemia treated with anagrelide: a case report. Korean J Hematol 2010;45(2):136–138. doi:10.5045/kjh.2010.45.2.136.
   PubMedGoogle Scholar
• Bosnjak I, Selthofer-Relatic K, Perisa V, Steiner R. Therapeutic dilemmas in the treatment of acute coronary syndrome as manifestation of essential thrombocythaemia. J Cardiol Cases 2013;8(5):168–171. doi:10.1016/j.jccase.2013.08.001.
   PubMedGoogle Scholar
• Schaaf M, Sibellas F. Acute myocardial infarction and anagrelide. Int J Cardiol 2013;168(2). doi:10.1016/j.ijcard.2013.06.110.
   PubMed Web of Science ®Google Scholar
• Bhat T, Ahmed M, Baydoun H, Ghandour Z, Bhat A, McCord D. Acute ST-segment elevation myocardial infarction in a young patient with essential thrombocythemia: a case with long-term follow-up report. J Blood Med 2014;5:123–127. doi:10.2147/JBM.S53539.
   PubMedGoogle Scholar
• Isilak Z, Tezcan M, Atalay M, Kardesoglu E. Acute myocardial infarction and sub-acute stent thrombosis associated with occult essential thrombocythemia. Chin Med J 2014;127(19):3512–3513.
   PubMed Web of Science ®Google Scholar
• Xiong N, Gao W, Pan J, Luo X, Shi H, Li J. Essential thrombocythemia presenting as acute coronary syndrome: case reports and literature review. J Thromb Thrombolysis 2017;44(1):57–62. doi:10.1007/s11239-017-1490-4.
   PubMed Web of Science ®Google Scholar
• Rotta Detto Loria J, Rawluk J, Krauss T, Bode C, Moser M, Helbing T. Acute transmural myocardial infarction by coronary embolism in a patient with JAK2 V617F-positive essential thrombocythemia. Hamostaseologie 2017;99(99). doi:10.5482/HAMO-16-12-0046.
   PubMedGoogle Scholar
• Shoji K, Yanishi K, Shiraishi J, Nakanishi N, Zen K, Nakamura T, Hyogo M, Shirayama T, Matoba S, Sawada T. In-stent massive thrombi formation during primary percutaneous coronary intervention in a patient with acute myocardial infarction complicated with essential thrombocythemia. Internal Med 2019;58(9):1287–1293. doi:10.2169/internalmedicine.2083-18.
   PubMed Web of Science ®Google Scholar